Orlando Magic · — · #—
—
| Period | GP | MIN | PTS | REB | AST | PRA | STL | BLK | TOV | 2PM | 2PA | 2P% | 3PM | 3PA | 3P% | FTM | FTA | FT% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Last 3 | 3 | 23.6 | 20.7 | 2.0 | 2.3 | 25.0 | 0.3 | 0.3 | 2.0 | 5.3 | 10.0 |
| 53.3% |
| 2.0 |
| 4.7 |
| 42.9% |
| 4.0 |
| 5.0 |
| 80.0% |
| Last 5 | 5 | 21.6 | 18.2 | 3.0 | 2.0 | 23.2 | 0.4 | 0.4 | 1.8 | 5.6 | 9.6 | 58.3% | 1.2 | 3.6 | 33.3% | 3.4 | 4.2 | 81.0% |
| Last 10 | 10 | 21.8 | 15.4 | 3.1 | 2.5 | 21.0 | 0.4 | 0.2 | 1.5 | 4.5 | 8.6 | 52.3% | 1.2 | 3.9 | 30.8% | 2.8 | 3.4 | 82.4% |
| Last 20 | 20 | 25.9 | 18.8 | 4.5 | 3.0 | 26.1 | 0.8 | 0.2 | 1.4 | 5.8 | 10.4 | 55.3% | 1.1 | 3.5 | 33.3% | 3.8 | 4.7 | 81.7% |
| Season | 34 | 30.0 | 20.6 | 5.2 | 3.3 | 29.1 | 0.9 | 0.3 | 1.7 | 5.8 | 10.8 | 53.3% | 1.4 | 4.1 | 34.5% | 4.8 | 5.8 | 82.3% |
high usage, high on-ball creation, high assist rate, low rim finishing off the ball
2025-26 season · fitted over 2022-23–2025-26
Style profile over 446 qualified players (8+ games, 10+ min/game). 100% is an identical profile; 50% is unrelated.
| Date | Matchup | W/L | MIN | PTS | REB | AST | STL | BLK | TOV | FGM | FGA | FG% | 3PM | 3PA | 3P% | FTM | FTA | FT% | +/- |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-12 | ORL @ BOS | L | 26.2 | 20 | 4 | 1 | 1 | 0 | 1 | 7 | 18 | 38.9% | 2 | 7 | 28.6% | 4 | 4 | 100.0% | -4.0 |
| 2026-04-10 | ORL @ CHI | W | 22.9 | 25 | 2 | 4 | 0 | 0 | 3 | 8 | 13 | 61.5% | 3 | 5 | 60.0% | 6 | 9 | 66.7% | 12.0 |
| 2026-04-08 | ORL vs. MIN | W | 21.6 | 17 | 0 | 2 | 0 | 1 | 2 | 7 | 13 | 53.8% | 1 | 2 | 50.0% | 2 | 2 | 100.0% | 20.0 |
| 2026-04-05 | ORL @ NOP | W | 20.3 | 11 | 5 | 2 | 0 | 1 | 0 | 4 | 10 | 40.0% | 0 | 1 | 0.0% | 3 | 4 | 75.0% | 10.0 |
| 2026-04-03 | ORL @ DAL | W | 17.1 | 18 | 4 | 1 | 1 | 0 | 3 | 8 | 12 | 66.7% | 0 | 3 | 0.0% | 2 | 2 | 100.0% | 18.0 |
| 2026-04-01 | ORL vs. ATL | L | 19.8 | 12 | 1 | 2 | 0 | 0 | 1 | 5 | 13 | 38.5% | 0 | 6 | 0.0% | 2 | 3 | 66.7% | -12.0 |
| 2026-02-11 | ORL vs. MIL | L | 20.6 | 5 | 0 | 3 | 2 | 0 | 0 | 1 | 7 | 14.3% | 1 | 5 | 20.0% | 2 | 2 | 100.0% | -9.0 |
| 2026-02-09 | ORL vs. MIL | W | 16.6 | 14 | 2 | 5 | 0 | 0 | 1 | 6 | 10 | 60.0% | 2 | 4 | 50.0% | 0 | 0 | 0.0% | 7.0 |
| 2026-01-18 | ORL @ MEM | L | 25.9 | 14 | 4 | 3 | 0 | 0 | 0 | 5 | 13 | 38.5% | 0 | 2 | 0.0% | 4 | 4 | 100.0% | -20.0 |
| 2026-01-15 | ORL @ MEM | W | 26.7 | 18 | 9 | 2 | 0 | 0 | 4 | 6 | 16 | 37.5% | 3 | 4 | 75.0% | 3 | 4 | 75.0% | 5.0 |
| 2025-12-07 | ORL @ NYK | L | 7.3 | 7 | 3 | 1 | 1 | 0 | 0 | 3 | 4 | 75.0% | 1 | 1 | 100.0% | 0 | 0 | 0.0% | 4.0 |
| 2025-12-05 | ORL vs. MIA | W | 34.1 | 32 | 5 | 3 | 1 | 0 | 2 | 12 | 22 | 54.5% | 4 | 9 | 44.4% | 4 | 6 | 66.7% | 7.0 |
| 2025-12-03 | ORL vs. SAS | L | 35.9 | 25 | 4 | 6 | 2 | 1 | 0 | 9 | 17 | 52.9% | 1 | 1 | 100.0% | 6 | 7 | 85.7% | 8.0 |
| 2025-12-01 | ORL vs. CHI | W | 32.3 | 25 | 6 | 2 | 2 | 1 | 5 | 11 | 18 | 61.1% | 0 | 2 | 0.0% | 3 | 3 | 100.0% | -8.0 |
| 2025-11-28 | ORL @ DET | W | 36.0 | 21 | 7 | 1 | 3 | 0 | 1 | 8 | 19 | 42.1% | 0 | 3 | 0.0% | 5 | 6 | 83.3% | -23.0 |
| 2025-11-25 | ORL @ PHI | W | 26.6 | 21 | 5 | 3 | 1 | 0 | 1 | 8 | 13 | 61.5% | 1 | 2 | 50.0% | 4 | 6 | 66.7% | 22.0 |
| 2025-11-23 | ORL @ BOS | L | 27.7 | 15 | 8 | 5 | 0 | 0 | 2 | 5 | 10 | 50.0% | 0 | 1 | 0.0% | 5 | 8 | 62.5% | -17.0 |
| 2025-11-22 | ORL vs. NYK | W | 33.7 | 37 | 6 | 7 | 0 | 0 | 1 | 13 | 19 | 68.4% | 4 | 6 | 66.7% | 7 | 7 | 100.0% | 10.0 |
| 2025-11-20 | ORL vs. LAC | W | 29.9 | 20 | 6 | 3 | 1 | 0 | 1 | 5 | 13 | 38.5% | 0 | 2 | 0.0% | 10 | 12 | 83.3% | 16.0 |
| 2025-11-18 | ORL vs. GSW | W | 36.4 | 18 | 8 | 3 | 1 | 1 | 1 | 7 | 17 | 41.2% | 0 | 3 | 0.0% | 4 | 4 | 100.0% | 5.0 |
| 2025-11-16 | ORL @ HOU | L | 42.8 | 29 | 5 | 4 | 2 | 0 | 2 | 8 | 21 | 38.1% | 3 | 8 | 37.5% | 10 | 13 | 76.9% | 2.0 |
| 2025-11-14 | ORL vs. BKN | W | 37.1 | 25 | 6 | 5 | 0 | 0 | 3 | 7 | 17 | 41.2% | 3 | 9 | 33.3% | 8 | 10 | 80.0% | 15.0 |
| 2025-11-12 | ORL @ NYK | W | 36.8 | 28 | 9 | 4 | 2 | 1 | 0 | 10 | 22 | 45.5% | 2 | 7 | 28.6% | 6 | 8 | 75.0% | 21.0 |
| 2025-11-10 | ORL vs. POR | W | 36.4 | 19 | 9 | 6 | 1 | 2 | 2 | 5 | 10 | 50.0% | 1 | 2 | 50.0% | 8 | 8 | 100.0% | -1.0 |
| 2025-11-09 | ORL vs. BOS | L | 37.2 | 20 | 9 | 3 | 2 | 0 | 2 | 5 | 17 | 29.4% | 1 | 4 | 25.0% | 9 | 10 | 90.0% | 4.0 |
| 2025-11-07 | ORL vs. BOS | W | 37.3 | 27 | 6 | 6 | 0 | 1 | 3 | 9 | 18 | 50.0% | 2 | 7 | 28.6% | 7 | 7 | 100.0% | 0.0 |
| 2025-11-04 | ORL @ ATL | L | 34.0 | 18 | 5 | 2 | 0 | 0 | 4 | 6 | 15 | 40.0% | 0 | 3 | 0.0% | 6 | 6 | 100.0% | -19.0 |
| 2025-11-01 | ORL @ WAS | W | 30.8 | 25 | 6 | 6 | 3 | 0 | 1 | 8 | 19 | 42.1% | 2 | 5 | 40.0% | 7 | 7 | 100.0% | 24.0 |
| 2025-10-30 | ORL @ CHA | W | 34.2 | 21 | 5 | 3 | 1 | 0 | 2 | 8 | 16 | 50.0% | 3 | 6 | 50.0% | 2 | 2 | 100.0% | 23.0 |
| 2025-10-29 | ORL @ DET | L | 33.4 | 22 | 7 | 2 | 0 | 1 | 1 | 6 | 14 | 42.9% | 3 | 4 | 75.0% | 7 | 11 | 63.6% | -15.0 |
| 2025-10-27 | ORL @ PHI | L | 36.2 | 22 | 4 | 4 | 0 | 1 | 0 | 8 | 12 | 66.7% | 1 | 4 | 25.0% | 5 | 7 | 71.4% | -12.0 |
| 2025-10-25 | ORL vs. CHI | L | 34.4 | 17 | 7 | 1 | 2 | 0 | 3 | 7 | 15 | 46.7% | 0 | 1 | 0.0% | 3 | 4 | 75.0% | -16.0 |
| 2025-10-24 | ORL vs. ATL | L | 35.1 | 27 | 6 | 2 | 1 | 0 | 4 | 10 | 17 | 58.8% | 2 | 5 | 40.0% | 5 | 6 | 83.3% | -2.0 |
| 2025-10-22 | ORL vs. MIA | W | 35.5 | 24 | 4 | 6 | 2 | 0 | 2 | 9 | 17 | 52.9% | 2 | 5 | 40.0% | 4 | 6 | 66.7% | 5.0 |